Research progress of monoclonal antibody in the treatment of adult acute lymphoblastic leukemia:reports from the 55th ASH annual meeting
10.3760/cma.j.issn.1009-9921.2014.04.001
- VernacularTitle:单克隆抗体治疗成年人急性淋巴细胞白血病研究进展:第55届美国血液学会年会报道
- Author:
Mingwei FU
;
Lugui QIU
- Publication Type:Journal Article
- Keywords:
Leukemia,lymphocytic,acute;
Immunotherapy;
ASH annual meeting
- From:
Journal of Leukemia & Lymphoma
2014;23(4):193-194
- CountryChina
- Language:Chinese
-
Abstract:
Humanized monoclonal antibody and CARs have became the focus of treatment in adult acute lymphoblastic leukemia (ALL) at the 55th ASH annual meeting.Treating with chemotherapy plus monoclonal antibody will get a develop effect in relapse/refractory adult ALL.More immune-pharmaceutics will be used in clinical trials.
